Evidence map›Paper›PMID 39561798›Full record

ArticleProceedings. Biological sciences2024

The evolution of post-infection mortality.

Chadi M Saad-Roy, Andy White, Mike Boots

Abstract read
In one paragraph

Article in Proceedings. Biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Final-Size Solutions for SIRI Models with Vaccination.Bulletin of mathematical biology · 2026
    Article
  2. Article
  3. The evolution of post-infection mortality.Proceedings. Biological sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chadi M Saad-RoyMiller Institute for Basic Research in Science, University of California, Berkeley, CA, USA.ORCID 0000-0002-2217-3071
Andy WhiteMaxwell Institute for Mathematical Sciences and Department of Mathematics, Heriot-Watt University, Edinburgh, UK.
Mike BootsDepartment of Integrative Biology, University of California, Berkeley, CA, USA.ORCID 0000-0003-3763-6136

Funding

Adolph C. and Mary Sprague Miller Institute for Basic Research in Science, University of California BerkeleyBiotechnology and Biological Sciences Research CouncilDivision of Environmental Biology
6 · The paper itself

Abstract

COVID-19 infections have underlined that there can be substantial impacts on health after recovery, including elevated mortality. While such post-infection mortality (PIM) is clearly widespread, we do not yet have any understanding of its evolutionary dynamics. To address this gap, we use an eco-evolutionary model to determine conditions where PIM is evolutionarily favoured. Importantly, from a pathogen perspective, there are two potential 'resources': never-infected susceptibles and previously infected susceptibles (provided some reinfection is possible), and PIM only occurs in the latter. A key insight is that unlike classic virulence (i.e. during-infection mortality, DIM) PIM is neutral and not selected against in the absence of other trade-offs. However, PIM modulates characteristics of endemicity, and may also vary with other pathogen-specific components. If PIM is only correlated with transmission, recovery or DIM, it simply acts to modulate their impacts on the evolutionary outcome. On the other hand, if PIM trades off with the relative susceptibility to reinfection, there are important evolutionary implications that contrast with DIM. We find settings where a susceptibility-mortality trade-off (i.e. an increase in mortality leads to higher relative susceptibility to reinfection) can select against DIM but favour PIM. This provides a potential explanation for the ubiquity of PIM. Overall, our work illustrates that PIM can readily evolve in certain settings and highlights the importance of considering different sources of mortality.

Indexed as

Biological EvolutionCOVID-19Disease SusceptibilityHumansSARS-CoV-2Virulenceeco-evolutionary modelpathogen evolutionpost-infection mortality

Identifiers

PMID39561798
PMCPMC11576100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.